Treatment With Intent to Generate Endovascular Reperfusion

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 9, 2018

Primary Completion Date

April 15, 2020

Study Completion Date

June 30, 2020

Conditions
Ischemic Stroke
Interventions
DEVICE

Tigertriever revascularization device

Mechanical Thrombectomy

Trial Locations (17)

11219

Maimonides Medical Center, Brooklyn

14203

University of Buffalo, Buffalo

15213

UPMC, Pittsburgh

30060

WellStar Research Institute, Marietta

32207

Baptist Health Research Institute, Jacksonville

33076

Tenet Health, Coral Springs

33176

Baptist Health South Florida, Miami

33316

University of Miami, Miami

43214

Riverside Methodist Hospital, Columbus

43604

Mercy Health, Toledo

52242

University of Iowa, Iowa City

78550

VBMC Harlingen, Harlingen

90095

UCLA medical center, Los Angeles

91360

Los Robles, Thousand Oaks

97239

Oregon Health & Science University, Portland

01655

University of Massachusetts, Worcester

Unknown

Rambam, Haifa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Rapid Medical

INDUSTRY

NCT03474549 - Treatment With Intent to Generate Endovascular Reperfusion | Biotech Hunter | Biotech Hunter